Back
RAPP long @ 27.54

Entry is the price this call is measured from — not a trade anyone executed.

19.59 28.54 37.50 46.45 55.40 Aug 27 Sep 14 Sep 29 Oct 14 Oct 29 apesalpha.com TRADED Oct 22 ENTRY 27.54
Entry 27.54 At close 24.21 -12.1% vs entry 5 sessions since the post 2026-08-27 → 2026-10-29 traded Oct 22, filed later

5 different insiders at Rapport Therapeutics, Inc. just bought RAPP.

  1. The cluster: 5 people, $1,566,347 between them in the last 30 days, each paying their own price separately.
  2. The biggest buy: Steven M Paul (Director), 35,714 shares at $27.28 on 22 October 2026. That is the entry above -- a Form 4 discloses the price actually paid, so this is a real fill, not an estimate. It is what they paid on their own trade date, though, not a price available now.

Also buying: John Maraganore (Director, $248,891), Troy A. Ignelzi (Chief Financial Officer, $143,550), Wendy B. Young (Director, $99,992), Paul M Silva (Director, $99,636).
3. Filed: 22 October 2026.

Risk: several different people buying is the whole signal -- one person buying repeatedly is one decision. Grants, option exercises and tax withholdings are excluded, since none of those is anybody choosing to put money in. An automated tracker of public SEC filings, not a recommendation.

· Thu, 22 Oct · · 12 views 7 clicks

0 comments

No comments yet.

You’re posting as a guest. Sign in to post under your own name.